Human β 2 -glycoprotein I is a heavily glycosylated fivedomain plasma membrane-adhesion protein, which has been implicated in blood coagulation and clearance of apoptotic bodies from the circulation. It is also the key antigen in the autoimmune disease anti-phospholipid syndrome. The crystal structure of β 2 -glycoprotein I isolated from human plasma reveals an elongated fishhook-like arrangement of the globular short consensus repeat domains. Half of the C-terminal fifth domain deviates strongly from the standard fold, as observed in domains one to four. This aberrant half forms a specific phospholipid-binding site. A large patch of 14 positively charged residues provides electrostatic interactions with anionic phospholipid headgroups and an exposed membrane-insertion loop yields specificity for lipid layers. The observed spatial arrangement of the five domains suggests a functional partitioning of protein adhesion and membrane adhesion over the Nand C-terminal domains, respectively, separated by glycosylated bridging domains. Coordinates are in the Protein Data Bank (accession No. 1QUB).
Introduction
Human β 2 -glycoprotein I (β2GPI), also known as apolipoprotein H, is a membrane-adhesion glycoprotein present in blood plasma at a concentration of~150-300 µg/ml (Willems et al., 1996) . It consists of 326 amino acid residues (Lozier et al., 1984; Kristensen et al., 1991) with 20% w/w carbohydrates attached. β2GPI is the key antigen in the autoimmune disease anti-phospholipid syndrome (APS), defined by thrombo-embolic complications and the presence of anti-phospholipid autoantibodies (aPLs) in the blood. β2GPI has been indicated as a natural 5166 © European Society of Human Reproduction and Embryology anticoagulant (Brighton et al., 1996; Mori et al., 1996) and has a role in the clearance of apoptotic bodies from the circulation (Price et al., 1996; Balasubramanian and Schroit, 1998; Manfredi et al., 1998) . β2GPI belongs to a super-family of proteins characterized by repeating stretches of~60 amino acid residues, each with a set of 16 conserved residues and two fully conserved disulfide bonds. More than 50 mammalian, mainly complement, proteins belong to this family including CR2, Factor H and CR1, which contain up to 15, 20 and 30 of these consecutive repeating stretches, respectively (Bork et al., 1996) . These repeating units have been termed short consensus repeat (SCR), complement control protein or Sushi domains and are, in many cases, involved in proteinprotein interactions, with typically two to four consecutive domains forming an interaction site (Iwata et al., 1995; Sharma et al., 1996; Blom et al., 1999; Casasnovas et al., 1999; van de Poel et al., 1999) . NMR structures of two single SCR domains, domains 5 and 16 of human Factor H (HFH) (Norman et al., 1991; Barlow et al., 1992) , and two SCR domains in tandem, domains 15-16 of HFH and domains 3-4 of vaccinia virus complement control protein (VCP) (Barlow et al., 1993; Wiles et al., 1997) , have been determined. Recently, the crystal structure of the N-terminal two SCR domains of CD46 has been published (Casasnovas et al., 1999) . β2GPI consists of five of these SCR domains. The first four domains are regular SCR domains with respect to their amino acid sequences. The fifth C-terminal domain contains a six-residue insertion and a 19-residue C-terminal extension, which is C-terminally cross-linked by a disulfide bond. This aberrant domain is responsible for adhesion to acidic phospholipids (Steinkasserer et al., 1992; Hunt and Krilis, 1994; Sheng et al., 1996) . Adhesion to membranes is very likely to be an essential aspect of β2GPI that is common to the observed effects of β2GPI in APS, coagulation and apoptosis.
The autoimmune disorder APS is characterized by the presence of a group of heterogeneous autoantibodies in blood plasma and the occurrence of thrombo-embolic complications in both the arterial and venous vasculature of patients (Bick and Baker, 1994) . The symptoms appear predominantly in women aged 25-35 years. A particular problem in understanding the pathophysiology of aPLs has been the apparent contradiction between the in vivo observed thrombosis and the in vitro observed prolonged coagulation time (Brighton et al., 1996) . An important observation has been that the real antigen for aPLs is the plasma-protein β2GPI (Galli et al., 1990) and not phospholipids (Roubey, 1996) . The affinity of β2GPI for acidic phospholipids increases strongly in the presence of aPLs, which is explained by the formation of divalent (β2GPI) 2 -aPL complexes (Willems et al., 1996) . Binding of these complexes to phospholipids interferes with the binding of other phospholipid-binding proteins in plasma, such as coagulation proteins, resulting in the in vitro prolongation of coagulation (Takeya et al., 1997) . In vivo, the (β2GPI) 2 -aPL complexes possibly inhibit the anticoagulant activity of protein C at phospholipid surfaces, explaining the thrombo-embolic risk (Esmon et al., 1997) .
We have determined the crystal structure of the glycosylated five-domain human β2GPI purified from blood plasma to a resolution of 2.7 Å. The structure aids the characterization of the epitopes for the heterogeneous pool of aPLs and yields insights into the spatial arrangement and functional partitioning over the multiple consecutive SCR domains and the mechanism of binding to acidic phospholipids.
Results

Structure determination
Crystals of β2GPI grew in the orthorhombic space group C222 1 . Significant non-isomorphism was observed between crystals, as indicated by an R iso of 20.9% between data sets Native I and Native II (Table I) . Structure determination of β2GPI with the multiple-isomorphous replacement method using anomalous scattering (MIRAS) revealed one β2GPI molecule in the asymmetric unit with a remarkably high solvent content of 86% and a large V m value of 8.5 Å 3 /Da (Table II, Figure 1 ). The initial map using Native I and derivative set I was of low quality due to poor phasing statistics (Table II) and was improved dramatically by solvent flattening using a solvent fraction of 70%. A first model was built at 3.75 Å resolution using the NMR structure of the 15th SCR domain of HFH (Barlow et al., 1993) . Rigid-body refinement of this initial model against data set Native II yielded a decrease in R-factor from 52.6 to 48.0% and in R free from 52.0 to 47.8%. Phase information to 2.7 Å resolution obtained at a later stage (derivative sets II) was used to validate and correct the model (Figure 2) . Refinement used the maximum-likelihood method and a bulk-solvent correction (see Materials and methods). Electron density corresponding to residues Ser311-Lys317 is not visible in the final 2F o -F c map and, therefore, these residues have not been included in the final model. Seven carbohydrate units are identified in the electron density maps at the four N-glycosylation sites. The final structure is refined to 2.7 Å resolution with an R-factor of 24.9% and 5167 an R free of 26.9% and displays good stereochemistry (Table II) . Coordinates and structure factors have been deposited with the Protein Data Bank (accession No. 1QUB).
Structure description
The structure of β2GPI shows an extended chain of five SCR domains with an overall fish-hook-like appearance with dimensions of 130 Å (vertical direction in Figure 1A ), 85 Å (horizontal) and 130 Å from the N-to C-terminal extremity. The distance from the N-to C-terminal end along the curve of the molecule is~190 Å. The fish-hook shape is mostly flat, but is bent slightly around domain III. The elongated structure contradicts a hypothetical model of Koike et al. (1998) , who described the molecule as being folded into a compact particle.
Domains I-IV of β2GPI have common SCR folds ( Figure 1B) . They consist of a central anti-parallel β-sheet, comprising strands B2-B3-B4, with two extended loops typically flanked by short two-stranded anti-parallel β-sheets, B1Ј-B2Ј and B4Ј-B5Ј, at the N-and C-terminal side ( Figure 1C ). Disulfide bridges located at opposite ends of a domain cross-link the short-flanking β-sheets with the central β-sheet (B1Ј-B4 and B3-B5Ј). Domain II has slightly deviating structural elements; its central sheet is extended by one more anti-parallel strand denoted B5 and residues at the position of strand B1Ј-B2Ј do not adopt a β-sheet conformation. These four domains of β2GPI have a sequence homology ranging from 24 to 45% (Corpet, 1988) and superpose within 1.2-1.9 Å rootmean-square (r.m.s.) coordinate difference (see Materials and methods). A similar range of homology, 21-41%, and a similar range of r.m.s. coordinate difference, 1.4-2.3 Å, are observed when comparing β2GPI I-IV with SCR domains available in the Protein Data Bank, HFH-15, 16 (Barlow et al., 1993) and VCP-3, 4 (Wiles et al., 1997) . This indicates that the SCR fold is very well conserved. The largest differences with respect to amino acid length and structure are observed in the B2-B2Ј loops, referred to as 'hyper-variable' by Barlow et al. (1993) .
The fifth C-terminal domain deviates significantly from the common SCR fold ( Figure 1D ). Similar to the SCR fold, it has the central anti-parallel β-sheet encompassing β-strands B2, B3 and B4 and the two disulfide bonds common to all SCR domains. In domain V, strands B3 and B4 of the central sheet are extended and are part of a larger and strongly twisted anti-parallel β-sheet. Domain V has an insertion of six residues in the region of the hyper-variable loop. This region now forms an additional β-strand (B2Љ), which participates in the central β-sheet, followed by a short α-helix (A1). The C-terminal extension contains a short 3/10 helix (A2) and is cross-linked C-terminally by a third disulfide bond. Residues 311-317 of this extension are not visible in the electron density map. This exposed loop is possibly mobile or disordered due to potential cleavage at Ala314-Phe315 or Lys317-Thr318 (Hunt et al., 1993; Hunt and Krilis, 1994) . In conclusion, domain V may be considered to consist of a core that is reminiscent of the consensus SCR fold with unique structural elements A1, A2 and B2Љ and the exposed loop 311-317 forming a completely new face of this domain with respect to other known SCR domains. 
2 ) e Phasing power is the r.m.s. value of the heavy atom structure factor amplitude divided by the r.m.s. residual lack of closure. f R cullis is the mean residual lack of closure error divided by the isomorphous difference. g FOM, figure of merit. h A 5% test set of reflections was used for calculation of R free .
Oligosaccharide antennae
As indicated by Kristensen et al. (1991) , human β2GPI contains four N-glycosylation sites. The electron density shows seven carbohydrate units at these four sites, namely
. Weak density at Thr130 indicates the position of an O-linked sugar (Gambino et al., 1997) , which is in agreement with the sequence context of glycosylated threonines (Hansen et al., 1995) . Four glycans (at positions 130, 143, 164 and 174) are located on domain III and one (at 234) on domain IV. Three glycans are positioned in the inner curve of the fish-hook, filling the niche formed by the molecule ( Figure 1A ). The remaining two glycans are located on domain III at the outer curve of the fish-hook. The five glycans point into large solvent channels present in the crystal. Crystal packing is dominated by interactions involving domains I, II and V. Very few crystal contacts involve domains III and IV (Figure 3) . Moreover, domains III and IV, which carry the glycans, appear to bridge between the contacts made by the N-and C-terminal 5168 domains I, II and V. The observed shielding of domains III and IV may reflect an indirect functional role of the glycans.
Interdomain flexibility
The domains in β2GPI are connected by short linker regions of three (between domains IV and V) and four residues (all others), i.e. counting the number of residues between the C-terminal cysteine of the first domain and the N-terminal cysteine of the second domain. Between domains II-III and III-IV these linking residues form β-strands that connect sheets B4Ј-B5Ј of the N-terminal domain with B1Ј-B2Ј of the C-terminal domain ( Figure 1A and B). The interactions observed at the interfaces are hydrophobic contacts with one hydrogen bond between domains I-II, II-III and III-IV and two hydrogen bonds between domains IV-V. Only a small amount (10-15%) of surface is buried at the interdomain interfaces: 422, 242, 445 and 492 Å 2 for domains I-II up to IV-V, respectively.
The four interdomain orientations observed in β2GPI display tilt angles (φ) varying from 128 to 160°and twist angles (ψ) varying from 41 to 137°(Table III, Figure 4) . Slightly different angles (up to 6°difference) are observed for the low-resolution data Native I, for which the b-axis is 2.8 Å shorter. The observed tilt angles (φ) in all known SCR domain-domain structures are obtuse and range from 120 to 162° (Table III) . The range observed for the twist 5169 angle (ψ) is much larger, 22-180°, which indicates a large variability in precise domain-domain interactions. Electron microscopy for CR2 (Moore et al., 1989) and HFH (Di Scipio, 1992) , which contain 15 and 20 SCR repeats, also show elongated and winding structures. In these proteins up to eight residues link the separate domains yielding further flexibility. These electron microscopy, NMR and X-ray data suggest that multiple SCR repeats form elongated and rather flexible chains. Table III ).
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Membrane binding
The fifth domain of β2GPI has been implicated in membrane binding (Steinkasserer et al., 1992) . In β2GPI we observe a large, positively charged area of~2000 Å 2 on domain V (Figure 5 ). This patch is formed by side chains of 12 lysines, one arginine and one histidine located at the outer curve of the fish hook. It includes four lysines from the loop Cys281-Cys288 and lysines 308 and 324, which are important for phospholipid binding (Steinkasserer et al., 1992; Hunt and Krilis, 1994; Sheng et al., 1996) . Other residues of this patch are Lys246, Lys250, Lys251, Arg260, Lys262, Lys266, Lys268 and His310. The flexible loop Ser311-Lys317, containing Trp316, which is essential for phospholipid binding (Sanghera et al., 1997) is located within this charged region ( Figure 5B) .
The structural and biochemical data indicate a relatively simple membrane-binding mechanism. The positive charges on domain V interact with the anionic phospholipid headgroups and the flexible loop Ser311-Ser-Leu-AlaPhe-Trp-Lys317 putatively inserts into the lipid layer and positions Trp316 at the interface region between the acyl chains and phosphate headgroups of the lipids, thereby anchoring the protein molecule to the membrane ( Figure 5C ). Furthermore, the combination of Trp, Phe or Tyr, followed by a Lys, is of particular importance for the interaction with the interfacial region between the lipid phosphate group and the acyl chains of lipids (Stopar et al., 1996; Mall et al., 1998; Mangavel et al., 1998; de Planque et al., 1999) . Comparison of β2GPI sequences of bovine, canine, mouse, rat and human shows that the putative membrane-insertion loop Ser311-Lys317 is identical among these species and that substitutions with respect to a positively charged patch on domain V are conserved. Interestingly, all residues responsible for the unique function in membrane binding of domain V are located on the aberrant non-SCR-like half of this domain.
Reduced affinity for acidic phospholipids, as observed for the two naturally occurring mutants Cys306 to Gly and Trp316 to Ser (Sanghera et al., 1997; Horbach et al., 1998) and for three cleaved isoforms of β2GPI, with a Two values are given: the first value is obtained from β2GPI in crystal form II (cf. Native II), the second value refers to β2GPI in form I (Native I). b Reported standard deviations are 13°in φ and 17°in ψ (Wiles et al., 1997) . c Between the six copies of the molecule in the asymmetric unit a difference of 15°in φ is reported (Casasnovas et al., 1999) . d Reported standard deviations are 4°in φ and 6°in ψ (Wiles et al., 1997) .
scissile bonds between residues 314-315 and 317-318 (Hunt et al., 1993; Hunt and Krilis, 1994) , can be readily explained by the proposed membrane-binding model. Both mutations and the two scissile bonds disrupt the integrity of the putative membrane-insertion loop 311-317. We think that the in vitro observed binding properties to heparin of β2GPI with the single mutation Trp316 to Ser (Horbach et al., 1998) , and of two isoforms that are proteolytically cleaved between Lys317 and Thr318 and native β2GPI (Horbach et al., 1999) , show a non-specific behaviour of the protein, which is not affected by alterations or disruptions of the membrane-insertion loop and is brought about solely by charge interactions. The loop Ser311-Ser-Leu-Ala-Phe-Trp-Lys317, therefore, gives β2GPI its specificity for phospholipid interfaces by introducing specific hydrophobic interactions between amino acid residues and acyl chains of phospholipids, in addition to the large number of charge interactions.
Binding of anti-phospholipid autoantibodies
The group of autoantibodies, aPLs, detected in blood plasma of patients with APS is both inter-and intraindividually heterogeneous. Indeed, the extended shape of β2GPI offers many potential sites for antibody binding, particularly at the non-glycosylated domains I, II and V. So far, aPL binding to domains I, III, IV and V, and the interdomain region between I and II, has been reported (Hunt and Krilis, 1994; Wang et al., 1995; George et al., 1998; Iverson et al., 1998; Blank et al., 1999) . Wang et al. (1995) have identified two potential epitope sequences, Gly274-Phe280 and Ala314-Pro325. Based on the structure, both sequences are unlikely to be epitopes of aPLs. Gly274-Phe280 forms the central β-strand B3 of domain V, which is largely inaccessible to the solvent (17% solvent accessibility). It is, thus, unlikely to be either an epitope or a cryptic epitope, without fully disrupting the fifth domain. The second peptide, Ala314-Pro325 contains part of the putative membrane-insertion loop Ser311-Lys317. Binding of aPL to these residues will directly interfere with, if not fully abolish, membrane binding of β2GPI. This analysis shows that the crystal structure of β2GPI is an important tool for the evaluation of potential epitopes. It will guide mutational studies of β2GPI and aid in the characterization of antibodies related to APS. 
Discussion
The crystal structure of the intact and glycosylated adhesion protein β2GPI from human blood plasma reveals that its five consecutive SCR domains form an elongated chain giving an overall fish-hook shape to the molecule. Multiple consecutively arranged domains are common in adhesion molecules. However, very few structures of these repetitive domains have been resolved (Brady et al., 1993; Bodian et al., 1994; Leahy et al., 1996) , let alone those of complete adhesion molecules. The structure of complete β2GPI shows that the first four domains display regular SCR folds that are common to many mammalian complement proteins. The fifth domain has an aberrant fold. Constructed onto a SCR-like core, a six-residue insertion and 19-residue C-terminal extension, together with some rearrangement of existing elements, creates a completely new face on this domain. Strikingly, the structural and biochemical data strongly suggest that this new face of domain V is fully responsible for the membrane binding of β2GPI. The proposed mechanism of membrane binding consists of two major aspects: (i) a large positive patch of 14 charges binds to the anionic surface; and (ii) a flexible and partially hydrophobic loop inserts into the lipid layer and positions a Trp and a Lys at the interfacial region, thereby providing specificity for negatively charged phospholipid layers. Membrane adhesion of β2GPI probably underlies the diverse effects of this protein in blood coagulation, apoptosis and the APS immune disorder, in which autoantibodies enhance membrane affinity by divalent cross-linking of β2GPI. The observed crystal structure even bears relevance for the positioning of β2GPI domains when the molecule is membrane bound. It implies that association of the binding site, located at the top and outer curve of the fish-hook of β2GPI, with a membrane layer results in pointing domains IV to I far into the solution. Similar to what is observed in the crystal, the glycosylated domains III and IV are partially shielded from protein-protein interactions by the glycans and therefore may possibly be regarded as linker or 'bridging' domains. The N-terminal domains are exposed most to the solution and probably provide binding sites in, for example, apoptosis. Thus, the crystal structure of the complete and glycosylated adhesion molecule β2GPI suggests a functional partitioning over its three-dimensional structure that is probably a general phenomenon for many elongated multidomain adhesion molecules, as already observed, for example, in Factor H (Sharma et al., 1996) and C4BP (Blom et al., 1999) .
Materials and methods
Protein purification β2GPI was isolated from freshly frozen citrated human plasma of one healthy donor (Dutch Blood Bank) as described previously (Horbach et al., 1996) . Purified β2GPI appeared as a single band of 42 kDa on an SDS-PAGE gel under non-reducing conditions and has at least seven bands between pH 5.3 and 6.8 on a silver-stained Pharmacia PhastGel IEF 3-9. MALDI-TOF mass spectrometry analysis revealed a protein mass of 45 Ϯ 2 kDa (calculated mass 36.3 kDa), indicative of heterogeneity of the carbohydrate content and the presence of~40-60 carbohydrate moieties. N-terminal sequence analysis revealed that this terminus starts with Gly1-Arg2-Thr3-Cys4.
Crystallization, heavy-atom derivatives and data collection
Crystallization trials using the hanging-drop vapour diffusion method at 4°C were performed with β2GPI concentrated to 6.5 mg/ml in 150 mM NaCl, 50 mM Tris-HCl pH 7.3. Crystallization conditions were essentially as described by Saxena et al. (1998) . (Table I) . Heavy-atom derivatives were prepared by soaking crystals for 4 days in solutions containing either 3 mM K 2 OsO 4 , Na 3 IrCl 6 or K 2 PtCl 6 . Crystals were flash-frozen in a liquid nitrogen stream after equilibration in solutions with 43% (v/v) (Native I) or 30-35% (v/v) glycerol. X-ray data were collected using a Mar345 imaging plate [Hamburg, EMBL Outstation at the DESY synchrotron, beamline BW7B for data sets K 2 OsO 4 (I), Na 3 IrCl 6 (I) and K 2 PtCl 6 (I)], a MacScience DIP2020 imaging plate mounted on a Nonius FR-571 rotating anode (for Native I) and an ADSC 2 ϫ 2 CCD camera [Grenoble, EMBL Outstation at the ESRF synchrotron, beamline ID14-EH4 for Native II, K 2 OsO 4 (II) and K 2 PtCl 6 (II)]. Data collection was aided by use of STRATEGY (Ravelli et al., 1997) and data were processed and scaled using either DENZO and SCALEPACK (Otwinowski and Minor, 1996) or the CCP4 Program Suite (CCP4, 1994). Unit-cell dimensions are given in Table I . Differences in cell volumes of up to 3.1% were mainly caused by differences in the length of the b-axis.
Structure determination
Three heavy-atom derivatives were used for phasing by the MIRAS method (Table II) . Heavy-atom positions were located and refined and a set of phases was calculated with SOLVE (Terwilliger and Berendzen, 1999) using data sets Native I, K 2 OsO 4 (I), Na 3 IrCl 6 (I) and K 2 PtCl 6 (I). We were able to determine the presence of one β2GPI molecule in the asymmetric unit in the first electron density map phased at 3.75 Å resolution. Phases were improved by solvent flattening with a solvent fraction of 70% using the program suite CNS (Brünger et al., 1998) . The NMR structure of SCR domain 15 of HFH (Barlow et al., 1993) was used for global positioning of the five SCR domains of β2GPI. A first model was constructed consisting of all 326 residues with 102 residues replaced by Ala. At a later stage, phase information to 2.7 Å resolution was obtained from K 2 OsO 4 (II) and K 2 PtCl 6 (II) using Native II (Table II) 
Structure refinement
The model was refined against the Native II data set at 2.7 Å resolution. Cycles of rebuilding using O (Jones et al., 1991) and positional and B-factor refinement using model phases, using CNS, were performed until convergence. Cross-validation was used throughout the refinement. Refinement used the Maximum Likelihood algorithm (Pannu and Read, 1996) and bulk-solvent correction was applied as calculated by CNS. No electron density was visible for the loop Ser311-Lys317 in the final 2F o -F c electron density map, although some density indicated its position in the maps calculated with MIRAS phases at 2.7 and 3.75 Å resolution. This ill-defined, solvent-exposed region could not be modelled satisfactorily. In the vicinity of the four N-glycosylation sites, electron density was seen accounting for a total of seven carbohydrate moieties, namely
, which are included in the model. No electron density accounting for fucose units linked to GlcNac-Asn was seen. The mobility of the oligosaccharide antennae is reflected by high B-factors of the carbohydrate units, ranging from 50 to 99 Å 2 . Between Thr130 and Gly1 of a symmetry-related molecule, electron density was seen, which could possibly be ascribed to an O-linked oligosaccharide antenna attached to Thr130 (Hansen et al., 1995; Gambino et al., 1997) . Additional electron density, which may be accounted for by cadmium ions, is observed near His172, His216 and Glu309. Near Tyr207's hydroxyl group additional weak density is present that might be indicative of partial sulfatation. Side-chain positions of residues Arg2, Arg39, Lys 59, Lys110, Arg135, Gln158, Lys177, Lys208, Lys251, Lys284, Glu285, Lys286, Lys287, Lys308 and Glu309 are poorly defined. The average B-factors for the main-chain atoms (C α , C, O, N) of the domains (labelled I-V) are 41.6 Å 2 (I), 38.1 Å 2 (II), 52.7 Å 2 (III), 53.8 Å 2 (IV) and 57.9 Å 2 (V), with an average B-factor for all domains of 46.9 Å 2 . For all non hydrogen protein atoms (i.e. excluding glycans) the B-factors are 42.1 Å 2 (I), 39.3 Å 2 (II), 53.8 Å 2 (III), 54.8 Å 2 (IV) and 59.2 Å 2 (V), with an average B-factor for all domains of 48.0 Å 2 . The final model comprises β2GPI residues Gly1-His310, residues Thr318-Cys326, one mannose and six N-acetylglucosamine carbohydrate moieties, which accounts for~80% of the total mass of a β2GPI molecule and 32 ordered water molecules.
Crystal structure analysis Superpositions of SCR domains are calculated in O using first cysteine residues only, followed by superpositioning of C α positions of spatially related residues (distance cut-off 3.8 Å). R.m.s. coordinate differences of 1.2-2.3 Å are observed for superposing 39 to 59 residues of β2GPI domains I-IV, HFH domains 15, 16 and VCP domains 3, 4. Domaindomain orientations of β2GPI were calculated using 27 C α atoms from each domain, which superposed with r.m.s. coordinate differences of 1.17-1.50 Å, as calculated with O. All domains were translated to one origin and for each domain inertia tensors were calculated and diagonalized. One domain was rotated with respect to its preceding domain in such a way that their eigenvectors with the smallest eigenvalues, i.e. the main axes of the domains (labelled a and aЈ in Figure 4B ), were aligned (tilt angle φ). Next, a second rotation (twist angle ψ) was performed to align the eigenvectors (labelled b and bЈ in Figure 4B ) with the second-smallest eigenvalues. Definition of the tilt angle φ and twist angle ψ is according to Bork et al. (1996) . Molecular surfaces and electrostatic potentials were calculated using GRASP (Nicholls et al., 1993) . The model quality was checked using WHATIF (Vriend, 1990) and PROCHECK (Laskowski et al., 1993) . The Ramachandran plot for the final model comprising 319 amino acid residues, shows that 87.4% of these residues fall in the most favoured region with no residues in disallowed regions. Domain-domain contacts were calculated with LIGPLOT (Wallace et al., 1995) . Figures 1A, C, D and 4A were generated using MOLSCRIPT (Kraulis, 1991) .
